Advertisement
Advertisement
PTGX
Protagonist Therapeutics, Inc
143.00
USDSponsored
-0.70
-0.49%
Sep 18, 15:59 UTC -4
Closed
Pre-Market
149.26
+6.26
+4.38%
Protagonist Therapeutics, Inc Financial Snapshot
| Market Cap | 9.66B |
| Beta | 1.80 |
| Earnings Per Share (EPS) | 1.03 |
| Price-to-Book (P/B) Ratio | 10.93 |
| Operating Margin | 29.40% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | 138.83 |
| Return on Equity (ROE) | 12.03% |
| Current Ratio | 21.71% |
| Free Cash Flow | 169.73M |